General Information:

Id: 9,896
Diseases: Ciliary dyskinesia, primary
Ciliopathy
Homo sapiens
article
Reference: Fedick AM et al.(2015) Carrier frequencies of eleven mutations in eight genes associated with primary ciliary dyskinesia in the Ashkenazi Jewish population Mol Genet Genomic Med 3: 137-142 [PMID: 25802884]

Interaction Information:

Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103851

gene/protein

DNAI1

affects_activity of

in Ashkenazi jews
Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103978

gene/protein

DNAI2

affects_activity of

in Ashkenazi jews
Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103979

gene/protein

DNAH11

affects_activity of

in Ashkenazi jews
Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103980

gene/protein

DNAH5

affects_activity of

in Ashkenazi jews
Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103981

gene/protein

CCDC114

affects_activity of

in Ashkenazi jews
Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103982

gene/protein

CCDC65

affects_activity of

in Ashkenazi jews
Comment Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal recessive disorder that results from functional and ultrastructural abnormalities of motile cilia. Patients with PCD have diverse clinical phenotypes that include chronic upper and lower respiratory tract infections, situs inversus, heterotaxy with or without congenital heart disease, and male infertility, among others. In this report, the carrier frequencies for eleven mutations in eight PCD-associated genes (DNAI1, DNAI2, DNAH5, DNAH11, CCDC114, CCDC40, CCDC65, and C21orf59) that had been found in individuals of Ashkenazi Jewish descent were investigated in order to advise on including them in existing clinical mutation panels for this population. The carrier frequency results were as follows: 0.28% for the DNAI1 c.1490G>A mutation, 0.50% for the DNAI2 c.1304G>A mutation, 0.10% for the DNAH11 c.11929G>T mutation, 0.58% for the DNAH5 c.7502G>C mutation, 0.19% for the CCDC114 c.939delT mutation, 0.29% for the CCDC65 c.877_878delAT mutation, and 0.48% for the C21orf59 c.735C>G mutation.
Formal Description
Interaction-ID: 103983

gene/protein

CFAP298

affects_activity of

in Ashkenazi jews